Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
Ginkgo Bioworks Ginkgo Bioworks (US:DNA) Prnewswire·2026-01-13 13:00

BOSTON, Jan. 13, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) announced today that Co-Founder and CEO Jason Kelly is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2026 at 10:30 a.m. PT (1:30 p.m. ET). Further details, including slides, will be posted on the company's investor relations website at https://investors.ginkgobioworks.com/events. About Ginkgo Bioworks Ginkgo Bioworks Contacts: INVESTOR CONTACT: [email protected] MEDIA CONTACT: [email protec ...